全文获取类型
收费全文 | 1349篇 |
免费 | 64篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 45篇 |
妇产科学 | 16篇 |
基础医学 | 164篇 |
口腔科学 | 10篇 |
临床医学 | 164篇 |
内科学 | 302篇 |
皮肤病学 | 28篇 |
神经病学 | 38篇 |
特种医学 | 216篇 |
外科学 | 197篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 84篇 |
眼科学 | 8篇 |
药学 | 88篇 |
中国医学 | 2篇 |
肿瘤学 | 52篇 |
出版年
2022年 | 5篇 |
2021年 | 12篇 |
2020年 | 7篇 |
2019年 | 7篇 |
2018年 | 17篇 |
2016年 | 15篇 |
2015年 | 17篇 |
2014年 | 21篇 |
2013年 | 34篇 |
2012年 | 51篇 |
2011年 | 46篇 |
2010年 | 31篇 |
2009年 | 27篇 |
2008年 | 35篇 |
2007年 | 58篇 |
2006年 | 48篇 |
2005年 | 50篇 |
2004年 | 54篇 |
2003年 | 29篇 |
2002年 | 47篇 |
2001年 | 36篇 |
2000年 | 36篇 |
1999年 | 48篇 |
1998年 | 43篇 |
1997年 | 32篇 |
1996年 | 51篇 |
1995年 | 33篇 |
1994年 | 28篇 |
1993年 | 33篇 |
1992年 | 28篇 |
1991年 | 31篇 |
1990年 | 35篇 |
1989年 | 47篇 |
1988年 | 42篇 |
1987年 | 40篇 |
1986年 | 22篇 |
1985年 | 28篇 |
1984年 | 15篇 |
1983年 | 16篇 |
1982年 | 21篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1979年 | 12篇 |
1978年 | 11篇 |
1977年 | 18篇 |
1976年 | 21篇 |
1975年 | 14篇 |
1974年 | 9篇 |
1973年 | 8篇 |
1972年 | 7篇 |
排序方式: 共有1438条查询结果,搜索用时 15 毫秒
1.
R. H. Wiesner B. J. Steffen K. M. David A. H. Chu R. D. Gordon J. R. Lake 《American journal of transplantation》2006,6(7):1609-1616
Mycophenolate mofetil (MMF) used in a triple-drug regimen has been shown to decrease acute rejection rates, compared to a double-drug regimen. The impact of MMF on late acute rejection (LAR) episodes has not been well described. To investigate the risk of LAR (rejection > or = 6 months post-transplantation) data from the Scientific Registry of Transplant Recipients (SRTR) were used. We studied adult primary liver transplant recipients transplanted between June 1, 1995, and April 30, 2004, with hepatitis C virus (HCV) (n = 3356), hepatitis B virus (HBV) (n = 550) or a nonviral (n = 5740) primary cause of liver disease who were recorded as receiving continuous 3-(MMF + Tacro + steroids) versus 2-drug (Tacro + steroids) therapy for at least 6 months immediately post transplantation. Kaplan-Meier analysis showed significantly lower LAR rates 4 years post-transplant in 3- versus 2-drug HCV, HBV and nonviral disease patients. Multivariate regression confirmed 3- versus 2-drug therapy to be associated with a decreased risk of LAR. Late graft survival was significantly lower at 4 years post-transplant for patients with LAR 6-12 months post-transplantation versus patients with early rejection (78.0% vs. 87.0%, p < 0.001) and no rejection (88.1%, p < 0.001). Three-drug versus 2-drug therapy for a minimum of 6 months may offer a better treatment strategy to avoid the consequences and expense of LAR episodes. 相似文献
2.
Hysterosalpingography was performed in 31 patients by means of a low-dose scanning-beam digital radiographic system. The technique permits adequate evaluation of gynecologic abnormalities while allowing significant reduction in radiation: 2.4-mR (6.1 X 10(-7) C/kg) exposure to the skin and 0.7-mrad (7 X 10(-6) Gy) mean dose to the ovaries per image obtained. Sixteen patients demonstrated readily recognizable and documented abnormalities, corroborated by laparoscopy, laparotomy, or other supportive evidence. 相似文献
3.
4.
5.
6.
7.
8.
9.
C V Paya R H Wiesner P E Hermans J J Larson-Keller D M Ilstrup R A Krom S B Moore J Ludwig T F Smith 《Hepatology (Baltimore, Md.)》1992,16(1):66-70
In this study we evaluated the association between cytomegalovirus infection alone or in relation to human leukocyte antigen matching and the development of vanishing bile duct syndrome, a form of chronic hepatic allograft rejection. A total of 81 consecutive liver transplant recipients were studied. Cytomegalovirus infection developed in 46 recipients (57%), and vanishing bile duct syndrome occurred in 9 recipients (11%). Cytomegalovirus infection developed in only five of the nine patients with vanishing bile duct syndrome. Univariate analysis of pretransplant recipient/donor cytomegalovirus serological tests and human leukocyte antigen typing showed they were not significant risk factors for the development of vanishing bile duct syndrome. Time-dependent analysis of cytomegalovirus infection after transplantation as a risk factor for vanishing bile duct syndrome, in a multivariate analysis with human leukocyte antigen match, showed no statistical significance. In our study, no association was found between cytomegalovirus infection alone or in relation to class I or II human leukocyte antigen match and the subsequent development of vanishing bile duct syndrome. 相似文献
10.
Noninvasive metabolic magnetic resonance (MR) imaging reflecting glucose metabolism in the aldose-reductase-sorbitol (ARS) pathway was performed in the rabbit head; after administration of the fluorinated glucose analogue 3-fluoro-3-deoxy-D-glucose (3FD-glucose), fluorine-19 images were generated. Images of 3FD-glucose showed significant 3FD-glucose uptake by adipose tissue, indicating its buffering effects in case of excess loads of glucose. Images of 3-fluoro-3-deoxy-D-sorbitol (3FD-sorbitol) demonstrated the spatial distribution of aldose reductase activities and significant sorbitol accumulation in the lens. Images of 3-fluoro-3-deoxy-D-fructose (3FD-fructose) showed preferential uptake of fructose by muscle tissue. The extremely low toxicity of 3FD-glucose indicates promise for its clinical application in metabolic imaging. 相似文献